Elizabeth A Harrington Selected Research

Proteins (Proteins, Gene)

1/2019

Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth A Harrington Research Topics

Disease

16	Neoplasms (Cancer) 10/2023 - 03/2004
5	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2015
3	Disease Progression 01/2022 - 05/2015
3	Methylmalonic acidemia 11/2021 - 05/2016
2	Circulating Neoplastic Cells 01/2022 - 12/2018
2	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 12/2021
2	Carcinogenesis 12/2021 - 03/2004
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 10/2019
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Dyspepsia (Indigestion) 10/2019
1	Fatigue 10/2019
1	Nausea 10/2019
1	Stomach Neoplasms (Stomach Cancer) 10/2019
1	Vomiting 10/2019
1	Mucositis 10/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 05/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/2008
1	Mycosis Fungoides 05/2008
1	Lymphoma (Lymphomas) 05/2008
1	Aneuploidy (Aneuploid) 03/2004

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
5	olaparibIBA 01/2023 - 11/2021
4	Circulating Tumor DNAIBA 01/2023 - 12/2018
3	abirateroneIBA 01/2023 - 11/2021
3	vistusertibIBA 11/2021 - 08/2015
2	Estrogen ReceptorsIBA 01/2022 - 12/2018
2	AZD9496IBA 01/2022 - 12/2018
2	PlatinumIBA 12/2021 - 12/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2021 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2016
2	Phosphotransferases (Kinase)IBA 11/2018 - 03/2004
2	RNA (Ribonucleic Acid)IBA 03/2017 - 01/2016
2	ParaffinIBA 01/2016 - 07/2015
2	Formaldehyde (Formol)FDA Link 01/2016 - 07/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2023
1	enzalutamideIBA 01/2023
1	tofersenIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 12/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2021
1	acalabrutinibIBA 11/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2021
1	Rituximab (Mabthera)FDA Link 10/2019
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	LigandsIBA 12/2018
1	ceralasertibIBA 11/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2018
1	AZD0156IBA 11/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2017
1	EnzymesIBA 05/2016
1	Neutralizing AntibodiesIBA 05/2016
1	Methylmalonyl-CoA MutaseIBA 05/2016
1	Nucleic AcidsIBA 01/2016
1	AZD4547IBA 01/2016
1	PromegaIBA 01/2016
1	carboxyl radical (COO-)IBA 05/2015
1	fostamatinibIBA 05/2015
1	AZD8186IBA 01/2015
1	Docetaxel (Taxotere)FDA Link 01/2015
1	Vorinostat FDA Link 05/2008
1	Histone Deacetylase InhibitorsIBA 05/2008
1	tozasertibIBA 03/2004
1	Aurora KinasesIBA 03/2004

Therapy/Procedure

6	Therapeutics 01/2022 - 12/2018
4	Castration 01/2023 - 11/2021
1	Precision Medicine 01/2022
1	Stem Cell Transplantation 10/2019
1	Drug Therapy (Chemotherapy) 01/2015